CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 105 enrolled
Drug / intervention
Betamethasone Dipropionate / Betamethasone Sodium Phosphate +1 moredrug
Likely dose
Triamcinolone Acetonide 40mg/mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05139875
NCT05139875Phase 4Completed
CompareCT.gov

A Comparative Study of Betamethasone (Diprospan) and Triamcinolone Acetonide as Single Intra-Articular Injection in Knee Osteoarthritis, A Double-Blinded, Randomized Controlled Trial

Thammasat University·interventional·Posted Dec 1, 2021·Updated Aug 30, 2024

In Brief

A Phase 4 clinical trial evaluating Betamethasone Dipropionate / Betamethasone Sodium Phosphate and Triamcinolone Acetonide 40mg/mL for Knee Osteoarthritis. Completed, enrolled 105 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the efficacy of Intra-articular corticosteroid injection between Betamethasone (Diprospan) and Triamcinolone acetonide for treatment of knee osteoarthritis

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKnee Osteoarthritis
CountriesThailand
Collaborators--

Timeline

Phase 4CompletedFinished
20222023202420252026
First PostedDec 1, 2021
Enrollment StartJan 1, 2022
Primary CompletionApr 30, 2024
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 4.6 years ago

Interventions

Betamethasone Dipropionate / Betamethasone Sodium Phosphatedrug

Single intra-articular Betamethasone Dipropionate / Betamethasone Sodium Phosphate (Diprospan) injections to affected knee

Triamcinolone Acetonide 40mg/mLdrug

Single intra-articular Triamcinolone Acetonide injections to affected knee